Table 6.6a

Immunosuppression Use for Induction, 1993 to 2002

Recipients with Pancreas Transplant Alone (PTA) Transplants

	Year of Transplant
	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants	52	39	41	53	78	88	136	135	163	176
Tx With Immunosuppression Info	51	39	39	50	76	80	131	127	155	157
No Induction Drugs Recorded	98.0%	69.2%	41.0%	34.0%	40.8%	41.3%	36.6%	30.7%	38.1%	33.1%
Drugs	0.0%	0.0%	0.0%	0.0%	-	-	-	-	-	-
ALG
ATG	2.0%	-	10.3%	22.0%	13.2%	15.0%	7.6%	-	-	-
NRATG/NRATS	-	-	-	-	5.3%	-	0.8%	-	-	-
OKT3	0.0%	30.8%	48.7%	44.0%	39.5%	22.5%	6.9%	4.7%	3.2%	2.5%
Thymoglobulin	-	-	-	-	-	-	30.5%	48.0%	51.0%	58.0%
Zenapax	-	-	-	-	1.3%	31.3%	30.5%	43.3%	34.8%	34.4%
Simulect	0.0%	0.0%	0.0%	0.0%	0.0%	3.8%	11.5%	9.4%	3.2%	4.5%

Source: OPTN/SRTR Data as of August 1, 2003.

(-) = Drug not used anytime during the year.

Induction drugs include any reported antilymphocyte antibodies and antibodies directed against lymphocyte receptors.